https://www.healthdailyfinland.com/article/906945549-orion-pharma-s-odm-212-granted-orphan-drug-designation-in-mesothelioma-by-the-us-fda Health Daily Finland en PressRelease 2026-04-20T13:00:00+00:00 Orion Pharma’s ODM-212 Granted Orphan Drug Designation in Mesothelioma by the US FDA https://ml-eu.globenewswire.com/media/9e6a027a-eb6c-4e34-993e-b8295e6d598d/small/orionpharma-rgb-press-releases-jpg.jpg https://www.healthdailyfinland.com/article/906945573-orion-pharman-odm-212-molekyyli-on-saanut-fda-n-harvinaisl-kestatuksen-orphan-drug-designation-mesoteliooman-hoidossa Health Daily Finland en PressRelease 2026-04-20T13:00:00+00:00 Orion Pharman ODM-212-molekyyli on saanut FDA:n harvinaislääkestatuksen (Orphan Drug Designation) mesoteliooman hoidossa https://ml-eu.globenewswire.com/media/9e6a027a-eb6c-4e34-993e-b8295e6d598d/small/